Skip to main content
. 2020 Jul 13;302(3):763–777. doi: 10.1007/s00404-020-05682-4
Evidence-based recommendation
Level of Evidence LLA Grade of recommendation A Degree of consensus++
FSH should be used to diagnose peri- and postmenopause only in women between 40 and 45 years with climacteric symptoms or in women under the age of 40 years with suspected indicators of premature ovarian insufficiency